Clinical Trials Directory

Trials / Unknown

UnknownNCT02480478

Serum Autotaxin Levels in Cholestasis of Pregnancy

Diagnostic Accuracy of Serum Autotaxin Levels in Cholestasis of Pregnancy

Status
Unknown
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Sisli Hamidiye Etfal Training and Research Hospital · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

Intrahepatic cholestasis of pregnancy is the most common liver disease in pregnancy. It is is a pregnancy-specific liver disorder with onset mainly in the third trimester of pregnancy. ICP is characterized by pruritus, elevated serum fasting bile salts and transaminases and an increased risk of adverse fetal outcomes. Serum autotaxin levels were found highly sensitive and specific biomarker to to differentiate ICP from other pregnancy-related liver disorders or pruritic dermatoses. The purpose of the study is to determine the diagnostic accuracy of serum autotaxin activity in cholestasis of pregnancy.

Detailed description

Collected data will enable us to compare serum autotaxin levels in cholestasis of pregnancy and healthy control group.

Conditions

Timeline

Start date
2015-06-01
Primary completion
2016-06-01
Completion
2017-01-01
First posted
2015-06-24
Last updated
2016-04-20

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT02480478. Inclusion in this directory is not an endorsement.